Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/26/2017
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
12/22/2017
CFDA, NHFPC Solicit Comments on Measures for Filing Registration of Me...
12/22/2017
Zhejiang Medicine Terminates Development of Anticancer Puquitinib
12/21/2017
GMP Certificate Cancellation in China: Concern Or Relief?
12/21/2017
TRACON and Ambrx Announce License Agreement for Carotuximab in China
12/21/2017
Recent Executive Moves
12/21/2017
Janssen Enters License Agreement with Legend Biotech to Develop CAR-T ...
12/20/2017
Review of Chinese Drug Clinical Trials on the Official Registration Pl...
12/20/2017
Jacobson Pharma and Shanghai Henlius Biotech Tie Up to Tap Biosimilars...
12/20/2017
CDE Solicits Comments on Technical Guidance for Conditional Approval o...
12/20/2017
CFDA Seeks Comments on Regulation for Expanded Compassionate Use of Cl...
12/20/2017
Five Prime Therapeutics and Zai Lab Announce License Deal for Anti-FGF...
12/20/2017
Examination Practice of Antibody-Related Patent Applications In China
12/19/2017
Legal Debriefs: The Revised Administrative Measures for Drug Registrat...
12/19/2017
Highlights On China's Comprehensive Regulatory Reform of Drugs and Med...
12/19/2017
WHO to Train More Autism Counselors In China
12/19/2017
Hong Kong Helps Speed Up Development of New Treatments As Number of Cl...
12/19/2017
MSF Challenges Gilead's HCV Patent Application in China
12/18/2017
CFDA Drafts the Provisions for Drug Standards for Public Comments
12/18/2017
SMEI: Chinese Hospital Drug Market Growth Continued to Slide in H1/201...
12/18/2017
IQVIA: Hospital Market Share Rebounded with Flat Primary Healthcare in...
12/15/2017
Fujian Introduces New Policy to Differentiate Drug Products into Three...
12/15/2017
Recent Executive Moves
12/14/2017
CFDA Approves Expanded Indication of Eisai's Aricept to Severe AD
12/14/2017
CFDA Accepts Innovent Biologics' NDA for PD-1 Candidate IBI308
12/13/2017
CFDA Solicits Comments on Two Clinical Guidelines for Special Medical ...
12/13/2017
Galderma to Spin Off Drug Business in China
12/11/2017
Boai NKY Pharma to Buy BioVision for $290M
12/11/2017
BGI Genomics to Set Up JV with TCM Player Kangmei Pharma
12/11/2017
Bayer's Pharma Chief Praises China for Progress in New Drug Clinical R...
Page:
173
/
358
Total number of articles:
10740
:
[First]
[<<]
[171]
[172]
[173]
[174]
[175]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit